Kate L. Gifford, BAppSc (Optom), PhD, IMI Committee Chair
Queensland University of Technology, Brisbane, Australia
Committee members:
- Dr. Langis Michaud
- Dr. Tom Aller
- Dr. Pauline Kang
- Dr. Kathryn Richdale
- Prof. Carly Lam
- Mr. Jeroen Mulder
- Dr. Dirk Seidel
- Dr. Kathryn Saunders
- Dr. Maria Liu
- Dr. Willem Tideman
- Dr. Janis Orr
- Prof. Kathy Rose
The future research directions of myopia interventions and treatments are discussed, along with the provision of clinical references, resources, and recommendations for continuing professional education in this growing area of clinical practice.
Best practice clinical guidelines for myopia control involve an understanding of the epidemiology of myopia, risk factors, visual environment interventions, and optical and pharmacologic treatments, as well as skills to translate the risks and benefits of a given myopia control treatment into lay language for both the patient and their parent or care giver.
This report details evidence-based best practice management of the pre-, stable, and the progressing myope, including risk factor identification, examination, selection of treatment strategies, and guidelines for ongoing management.
Practitioner considerations such as informed consent, prescribing off-label treatment, and guides for patient and parent communication are detailed.
The future research directions of myopia interventions and treatments are discussed, along with the provision of clinical references, resources, and recommendations for continuing professional education in this growing area of clinical practice.
Keywords: myopia control, myopia progression, clinical considerations, patient communication, practitioner education
Translated versions of IMI clinical summaries are available at myopiainstitute.org
The publication costs of the International Myopia Institute reports were supported by donations from BHVI, Carl Zeiss Vision, CooperVision, Essilor, Alcon, and Vision Impact Institute.